DAPAGLIFLOZIN (DAPAGLIFLOZIN PROPANEDIOL MONOHYDRATE) — all Canadian products
4 DINs
4 marketed/approved
0 in shortage
Every Health Canada Drug Identification Number whose active ingredient is DAPAGLIFLOZIN (DAPAGLIFLOZIN PROPANEDIOL MONOHYDRATE), with holder, form, strength and current status, compared weekly against the Drug Product Database.
| DIN | Product | Company | Form | Route | Strength | Status | Shortage |
|---|---|---|---|---|---|---|---|
| 02435462 | FORXIGA | ASTRAZENECA CANADA INC | Tablet | Oral | DAPAGLIFLOZIN (DAPAGLIFLOZIN PROPANEDIOL MONOHYDRATE) 5 MG | Marketed | |
| 02435470 | FORXIGA | ASTRAZENECA CANADA INC | Tablet | Oral | DAPAGLIFLOZIN (DAPAGLIFLOZIN PROPANEDIOL MONOHYDRATE) 10 MG | Marketed | |
| 02449935 | XIGDUO | ASTRAZENECA CANADA INC | Tablet | Oral | DAPAGLIFLOZIN (DAPAGLIFLOZIN PROPANEDIOL MONOHYDRATE) 5 MG; METFORMIN HYDROCHLORIDE 850 MG | Marketed | |
| 02449943 | XIGDUO | ASTRAZENECA CANADA INC | Tablet | Oral | DAPAGLIFLOZIN (DAPAGLIFLOZIN PROPANEDIOL MONOHYDRATE) 5 MG; METFORMIN HYDROCHLORIDE 1000 MG | Marketed |
Browse other molecules: